CRISPR-based rapid molecular diagnostic developed for two forms of leukemia
Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions.
10 Oct 02:45 · News-Medical